Bone morphogenetic proteins: From basic studies to clinical approaches

Bone

Volumn 22, Issue 6, 1998, Pages 591-603

  Sakou, T ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Activin receptor (ActR); BMP receptor (BMPR); Bone morphogenetic protein (BMP); Chondro osteogenesis; Embryogenesis; Signaling mediators

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOGENIC PROTEIN 1; OSTEOGENIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; BONE CELL; CARTILAGE; CARTILAGE CELL; EMBRYO DEVELOPMENT; FRACTURE HEALING; HUMAN; HUMAN CELL; LIGAND BINDING; MORPHOGENESIS; MOUSE; NONHUMAN; OSSIFICATION; PROTEIN TRANSPORT; RAT; RECEPTOR BINDING; REVIEW;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; EMBRYONIC AND FETAL DEVELOPMENT; FRACTURE HEALING; HUMANS; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032101214     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00053-2     Document Type: Review

References (180)

1. 1. Aono, A., Hazama, M., Notoya, K., Taketomi, S., Yamasaki, H., Tsukuda, R., Sasaki, S., and Fujisawa, Y. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun 210:670-677; 1995.
2. 2. Asahina, I., Sampath, T. K., Nishimura, I., and Hauscka, P. V. Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J Cell Biol 123:921-933; 1993.
3. 3. Asahina, I., Sampath, T. K., and Hauschka, P. V. Human osteogenic protein-1 induces chondroblastic, osteoblastic and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 222:38-47; 1996.
4. 4. Attisano, L., Wrana, J. L., Cheifetz, S., and Massagué, J. Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68:97-108; 1992.
5. 5. Attisano, L. and Wrana, J. L. Signal transduction by members of the transforming growth factor-β superfamily. Cytokine Growth Factor Rev 7:327-339; 1996.
6. 6. Bentz, H., Nathan, R. M., Rosen, D. M., Armstrong, R. M., Thompson, A. Y., Segarini, P. R., Mathews, M. C., Pasch, J. R., Piez, K. A., and Seyedin, S. Purification and characterization of an unique osteoinductive factor from bovine bone. J Biol Chem 246:20805-20810; 1989.
7. 7. Blessing, M., Schirmacher, P., and Kaiser, S. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of trangenic mice: Inhibitor or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol 135:227-239; 1996.
8. 8. Bostrom, M. P. G., Lane, J. M., Berberian, W. S., Missri, A. A. E., Tomin, E., Weiland, A., Doty, S. B., Glaser, D., and Rosen, V. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13:357-367; 1995.
9. 9. Carey, D. and Liu, X. Expression of bone morphogenetic protein-6 messenger RNA in bovine growth plate chondrocytes of different size. J Bone Miner Res 10:401-405; 1995.
10. 10. Celeste, A. J., Iannazzi, J. A., Taylor, R. C., Hewick, R. M., Rosen, V., Wang, E. A., and Wozney, J. M. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87:9843-9847; 1990.
11. 11. Chang, S. C., Hoang, B., Thomas, J. T., Vukicevic, S., Luyten, F. P., Ryba, N. J. P., Kozak, C. A., Reddi, A. H., and Moos, M., Jr. Cartilage-derived morphogenetic protein. New members of the transforming growth factor-β superfamily predominantly express in long bones during human embryonic development. J Biol Chem 269:28227-28234; 1994.
12. 2. Exp Cell Res 195:509-515; 1991.
13. 13. Chen, T. L., Bates, R. L., Dudley, A., Hammonds, G., Jr., and Amento, E. Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells: Comparison with TGF-β1. J Bone Miner Res 6:1387-1393; 1991.
14. 14. Chen, X., Rubock, M. J., and Whiteman, M. A transcriptional partner for MAD proteins in TGF-β signaling. Nature 383:691-696; 1996.
15. 15. Cook, S. D., Baffes, G. C., Wolfe, M. W., Sampath, T. K., Rueger, D. C., and Whitecloud, T. S., III. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Jt Surg 76-A:827-838; 1994.
16. 16. Cook, S. D., Dalton, J. E., Tan, M. E., Whitecloud, T. S., III, and Rueger, D. C. In vivo evaluation of recombinant human osteogenic protein-1 (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 19:1655-1663; 1994.
17. 17. Cook, S. D. and Rueger, D. C. Osteogenic protein-1. Biology and application. Clin Orthop 324:29-38; 1996.
18. 18. Cox, K., Holtrop, M., D'Alessandro, J. S., Wang, E. A., Wozney, J. M., and Rosen, V. Histological and ultrastructural comparison of the in vivo activities of rhBMP-2 and rhBMP-5. J Bone Miner Res 6:S155; 1991.
19. 19. Cunningham, N. S., Paralkar, V., and Reddi, A. H. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor β1 mRNA expression. Proc Natl Acad Sci USA 89:11740-11744; 1992.
20. 20. Cunningham, N. S., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Reddi, A. H., and Lee, S.-J. Growth/differentiation factor-10: A new member of the transforming growth factor-β superfamily related to bone morphogenetic protein-3. Growth Factors 12:99-109; 1995.
21. 21. Dale, L., Howes, G., Price, B. M., and Smith, J. C. Bone morphogenetic protein 4: A ventralizing factor in early Xenopus development. Development 115:573-585; 1992.
22. 22. D'Alessandro, J. S., Cox, K. A., Israel, D. I., LaPan, P., Moutsatsos, I. K., Nove, J., Rosen, V., Ryan, M. C., Wozney, J. M., and Wang, E. A. Purification, characterization and activities of recombinant bone morphogenetic protein 5. J Bone Miner Res 6:S153; 1991.
23. 23. De Robertis, E. M. and Sasai, Y. A. Common plan for dorsoventral pattering in Bilateria. Nature 380:37-40; 1996.
24. 24. Derynck, R. TGF-β-receptor-mediated signaling. Trends Biochem Sci 19: 548-553; 1994.
25. 25. Derynck, R. and Zhang, Y. Intracellular signaling: The Mad way to do it. Curr Biol 6:1226-1229; 1996.
26. 26. Dewulf, N., Verschueren, K., Lonnoy, O., Morén, A., Grimsby, S., Vande Spiegel, K., Miyazono, K., Huylebroeck, D., and ten Dijke, P. Distinct spinal and temporal expression patterns of two type I receptor for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136:2652-2663; 1995.
27. 27. Dieudonné, S. C., Semeis, C. M., Goel, S. W., Vukicevic, S., Nulend, J. K., Sampath, T. K., Heldler, M., and Burger, E. H. Opposite effects of osteogenetic protein and transforming growth factor-β on chondrogenesis in cultured long bone rudiments. J Bone Miner Res 9:771-780; 1994.
28. 28. Dong, J., Albertini, D. F., Nishimori, K., Kumar, T. R., Lu, N., and Matzuk, M. M. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383:531-535; 1996.
29. 29. Dudley, A. T., Lyons, K. M., and Robertson, E. J. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807; 1995.
30. 30. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.-C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. Madr2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552; 1996.
31. 31. Fainsod, A., Deissler, K., Yelin, R., Marom, K., Epstein, M., Pillemer, G., Steinbeisser, H., and Bum, M. The dorsalizing and neural inducing gene follistatin is an antagonist of BMP 4. Mech Dev 63:39-50; 1997.
32. 32. Franzén, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.-H., and Miyazono, K. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75:681-692; 1993.
33. 33. Gitelman, S. E., Kobrin, M. S., Ye, J. Q., Lopez, A. R., Lee, A., and Derynck, R. Recombinant Vgr-1/BMP-6 expressing tumors induce fibrosis and enchondral bone formation in vivo. J Cell Biol 126:1595-1609; 1994.
34. 34. Gitelman, S. E., Kirk, M., Ye, J.-Q., Filvaroff, E. H., Kahn, A. J., and Derynck, R. Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells. Cell Growth Diff 6:827-836; 1995.
35. 35. Glansbeek, H., van Beuningen, H. M., Vitters, E. L., Morris, E. A., van der Kraan, P. M., and van den Berg, W. B. Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1α effects on proteoglycan synthesis and content. Arthritis Rheum 40:1020-1028; 1997.
36. 36. Graff, J. M., Bansal, A., and Melton, D. A. Xenopus mad proteins transduce distinct subsets of signals for the TGF-β superfamily. Cell 85:479-487; 1996.
37. 37. Gross, R. E., Mehler, M. F., Mabie, P. C., Zang, Z., Santschi, L., and Kessler, J. A. Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17:595-606; 1996.
38. 38. Hahn, S. A., Schutte, M., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353; 1996.
39. 39. Hammonds, R. G., Jr., Schwall, R., Dudley, A., Berkemeier, L., Lai, C., Lee, J., Cunningham, N., Reddi, A. H., Wood, W. I., and Mason, A. J. Bone-inducing activity of mature BMP-2b produced from a hybrid BMP-2a/2b precursor. Molec Endocrinol 5:149-155; 1991.
40. 40. Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y. Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Jr., Wrana, J. L., and Falb, D. The MAD-related protein smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89:1165-1173; 1997.
41. 41. Hayashi, K., Ishidou, Y., Yonemori, K., Nagamine, T., Origuchi, N., Maeda, S., Imamura, T., Kato, K., Yoshida, H., Sampath, T. K., ten Dijke, P., and Sakou, T. Expression and localization of bone morphogenetic proteins (BMPs) and BMP receptors in ossification of the ligamentum flavum. Bone 21:23-30; 1997.
42. 42. Hazama, M., Aono, A., Ueno, N., and Fujisawa, Y. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system. Biochem Biophys Res Commun 209:859-866; 1995.
43. 43. Helder, M. N., Özkaynak, E., Sampath, T. K., Luyten, F. P., Latin, V., Oppermann, H., and Vulkicevic, S. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. J Histochem Cytochem 10:1035-1044; 1995.
44. 44. Hiraki, Y., Inoue, H., Shigeno, C., Sanma, Y., Benty, H., Rosen, D. M., Asada, A., and Suzuki, F. Bone morphogenetic protein (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro. J Bone Miner Res 6:1373-1384; 1991.
45. 45. Hogan, B. L. M. Bone morphogenetic protein: Multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594; 1996.
46. 46. Holley, S. A., Jackson, P. D., Sasai, Y., Lu, B., De Robertis, E. M., Hoffmann, F. M., and Ferguson, E. L. A conserved system for dorsal-ventral patterning in insects and vertebrates involving sog and chordin. Nature 376:249-253; 1995.
47. 47. Holley, S. A., Neul, J. L., Attisano, L., Wrana, J. L., Sasai, Y., O'Conner, M. B., De Robertis, E. M., and Ferguson, E. L. The Xenopus dorsalizing factor noggin ventralizes Drosophila embryos by preventing DPP from activating its receptor. Cell 86:607-617; 1996.
48. 48. Hoodless, P. A., Haerry, T., Abdollah, S., Stapleton, M., O'Connor, M. B., Attisano, L., and Wrana, J. L. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85:489-500; 1996.
49. 49. Hoshi, K., Amizuka, N., Sakou, T., Kurokawa, T., and Ozawa, H. Fibroblasts of spinal ligaments pathologically differentiate into chondrocytes induced by recombinant human bone morphogenetic protein-2: Morphological examinations for ossification of spinal ligaments. Bone 21:155-162; 1997.
50. 50. Hötten, G. C., Matsumoto, T., Kimura, M., Bechtold, R. F., Kron, R., Ohara, T., Tanaka, H., Sato, Y., Okazaki, M., Shirai, T., Pan, H., Kawai, S., Pohl, J. S., and Kudo, A. Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 13:65-74; 1996.
51. 51. Hughes, F. J., Aubin, J. E., and Heersche, J. N. Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor beta. Bone Miner 19:63-74; 1992.
52. 52. Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanal, J., Kawabata, M., and Miyazono, K. Smad6 inhibits TGF-β superfamily signaling. Nature 389:622-626; 1997.
53. 53. Inada, M., Katagiri, T., Akiyama, S., Namiki, M., Komaki, M., Yamaguchi, A., Kamoi, K., Rosen, V., and Suda T. Bone morphogenetic protein-12 and -13 inhibit terminal differentiation of myoblasts, but do not induce their differentiation into osteoblasts. Biochem Biophys Res Commun 222:317-322; 1996.
54. 54. Ishidou, Y., Kitajima, I., Obama, H., Maruyama, I., Murata, F., Imamura, T., Yamada, N., ten Dijke, P., Miyazono, K., and Sakou, T. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res 10:1651-1659; 1995.
55. 55. Israel, D. I., Nove, J., Kerns, K. M., Kaufman, R. J., Rosen, V., Cox, K. A., and Wozney, J. M. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13:291-300; 1996.
56. 56. Johnson, E. E., Urist, M. R., and Finerman, G. A. M. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions: A preliminary report. Clin Orthop 230:257-265; 1988.
57. 57. Johnson, E. E., Urist, M. R., and Finerman, G. A. M. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. Clin Orthop 236:249-257; 1988.
58. 58. Johnson, E. E., Urist, M. R., and Finerman, G. A. M. Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP). Clin Orthop 250: 234-240; 1990.
59. 59. Jones, C. M., Lyons, K. M., Lapan, P. M., Wright, C. V., and Hogan, B. L. M. DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus mesoderm induction. Development 115:639-647; 1992.
60. 60. Kanatani, M., Sugimoto, T., Kaji, H., Kobayashi, T., Nishiyama, K., Fukase, M., Kumegawa, M., and Chihara, K. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 10:1681-1690; 1995.
61. 61. Kaplan, F. S., Tabas, J. A., and Zasloff, M. A. Fibrodysplasia ossificans progressiva: A clue from the fly? Calcif Tissue Int 47:117-125; 1990.
62. 62. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J. M., Fujisawa-Sehara, A., and Suda, T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766; 1994.
63. 63. Katagiri, T., Akiyama, S., Namiki, M., Komaki, M., Yamaguchi, A., Rosen, V., Wozney, J. M., Fijisawa-Sehara, A., and Suda T. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogen. Exp Cell Res 230:342-351; 1997.
64. 64. Kawaguchi, H., Kurokawa, T., Hoshino, Y., Kawahara, H., Ogata, E., and Matsumoto, T. Immunohistochemical demonstration of bone morphogenetic protein-2 and transforming growth factor-β in the ossification of the posterior longitudinal ligament of the cervical spine. Spine 17:33-36; 1992.
65. 65. Kessler, E., Takahara, K., Biniaminov, L., Brusel, M., and Greenspan, D. S. Bone morphogenetic protein-1: The type I procollagen C-proteinase. Science 271:360-362; 1996.
66. 66. King, J. A., Storm, E. E., Marker, P. C., Dileone, R. J., and Kingsley, D. M. The role of BMPs and GDFs in development of region-specific skeletal structures. Ann NY Acad Sci 785:70-79; 1996.
67. 67. Kingsley, D. M., Bland, A. E., Grubber, J. M., Marker, P. C., Russell, L. B., Copeland, N. G., and Jenkins, N. A. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell 71:339-410; 1992.
68. 68. Kingsley, D. M. The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146; 1994.
69. 69. Koenig, B. B., Cook, J. S., Wolsing, D. H., Ting, J., Tiesman, J. P., Correa, P. E., Olson, C. A., Pequet, A. L., Ventura, F., Grant, R. A., Chen, G.-X., Wrana, J. L., Massagué, J., and Rosenbaum, J. S. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14:5961-5974; 1994.
70. 70. Koga, H., Hayashi, K., Taketomi, E., Matsunaga, S., Yashiki, S., Fujiyoshi, T., Sonoda, S., and Sakou, T. Restriction fragment polymorphism of gene of α2(XI) collagen, bone morphogenetic protein-2, alkaline phosphatase and tumor necrosis factor α among ossification of posterior longitudinal ligament patients and control Japanese population. Spine 21:469-473; 1996.
71. 71. Kogawa, K., Nakamura, T., Sugino, K., Takio, K., Titani, K., and Sugino, H. Activin-binding protein is present in pituitary. Endocrinology 128:1434-1440; 1991.
72. 72. Kretzschmar, M., Doody, J., and Massagué, J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389:618-622; 1997.
73. 73. Kretzschmar, M., Liu, F., Hata, A., Doody, J., and Massagué, J. The TGF-β family mediator smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 11:984-995; 1997.
74. 74. Kriegestein, K., Suter-Crazzolara, C., Hötten, G., Pohl, J., and Unsicker, K. Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-β superfamily, on midbrain dopaminergic neurons. J Neurosci Res 42:724-732; 1995.
75. 75. Lane, J. M. and Sandhu, H. S. Current approaches to experimental bone grafting. Orthop Clin North Am 18:213-225; 1987.
76. 76. LaPan, P., Bauduy, M., Cox, K. A., D'Alessandro, J. S., Israel, I., Nove, J., Rosen, V., Wozney, J. M., Moutsatsos, I. K., and Wang, E. A. Purification, characterization and activities of recombinant human bone morphogenetic protein 4. J Bone Miner Res 6:S153; 1991.
77. 77. Lein, P., Johnson, M., Guo, X., Rurger, D., and Higgins, D. Osteogenic protein-1 induces dendritic growth in rat sympathetic neurons. Neuron 15: 597-605; 1995.
78. 78. Lido, M., Eriksen, E. F., and Bünger, C. Bone morphogenetic protein-2 but both bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone 18:53-57; 1996.
79. 79. Lin, H. Y. and Lodish, H. F. Receptors for the TGF-β superfamily. Trends Cell Biol 11:972-978; 1993.
80. 80. Lind, M., Deleuran, B., Thestrup-Pedersen, K., Soballe, K., Eriksen, E. F., and Bunger, C. Chemotaxis of human osteoblast. Effect of osteotropic growth factors. APMIS 103:140-146; 1995.
81. 81. Liu, F., Ventura, F., Doody, J., and Massagué, J. Human type II receptor for bone morphogenetic proteins (BMPs): Expression of the two-kinase receptor model to the BMPs. Mol Cell Biol 15:3479-3486; 1995.
82. 82. Liu, F., Hata, A., Baker, J. C., Doody, J., Cárcano, J., Harland, R. M., and Massagué, J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381:620-623; 1996.
83. 83. Luo, G., Hofmann, C., Bronckers, A. L. J. J., Sohocki, M., Bradley, A., and Karsently, G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820; 1995.
84. 84. Luyten, F. P., Cunningham, N. S., Ma, S., Muthukermaran, N., Hammonds, R. G., Nevins, W. B., Wood, W. I., and Reddi, A. H. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem 264:13377-13380; 1989.
85. 85. Luyten, F. P., Yu, Y. M., Yanagishita, M., Vukicevic, S., Hammonds, R. G., and Reddi, A. H. Natural bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures. J Biol Chem 267:3691-3695; 1992.
86. 86. Lyons, K. M., Pelton, R. W., and Hogan, B. L. M. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-β-like genes coordinately regulate aspects of embryonic development. Genes Dev 3:1657-1668; 1989.
87. 87. Macías-Silva, M., Abdollah, S., Hoodless, P. A., Pirone, R., Attisano, L., and Wrana, J. L. MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215-1224; 1996.
88. 88. Maliakal, J. C., Asahina, I., Hauscka, P. V., and Sampath, T. K. Osteogenic protein-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cells. Growth Factors 11:227-234; 1994.
89. 89. Massagué, J. TGF-β signaling: Receptors, transducers, and mad proteins. Cell 85:947-950; 1996.
90. 90. Massagué, J. and Weis-Gracia, F. Serine/threonine kinase receptors: Mediators of transforming growth factor β signals. Cancer Surv 27:41-64; 1996.
91. 91. Mathews, L. S. and Vale, W. W. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65:973-982; 1991.
92. 92. McPherron, A. C., Lawler, A. M., and Lee, S. J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83-90; 1997.
93. 93. Meersseman, G., Versheueren, K., Nelles, L., Blumenstiock, C., Kraft, H., Wuytens, G., Remacle, J., Kozak, C. A., Tylzanowski, P., Nierhs, C., and Huylebroeck, D. The C-terminal domain of mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation. Mech Dev 61:127-140; 1997.
94. 94. Mishina, Y., Suzuki, A., Ueno, N., and Behringer, R. R. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 9:3027-3037; 1995.
95. 95. Miyasaka, K., Kaneda, K., Ito, T., Takei, H., Sugimoto, S., and Tsuru, M. Ossification of spinal ligaments causing thoracic radiculopathy. Neuroradiology 143:463-468; 1982.
96. 96. Miyazono, K., ten Dijke, P., Yamashita, H., and Heldin, C.-H. Signal transduction via serine/threonin kinase receptors. Semin Cell Biol 5:389-398; 1994.
97. 97. Nagamine, T., Imamura, T., Ishidou, Y., Kato, M., Murata, F., ten Dijke, P., and Sakou, T. Immunohistochemical detection of activin A, follistatin and activin receptors during fracture healing in rats. Unpublished.
98. 98. Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., and Sugino, H. Activin-binding protein from rat ovary is follistatin. Science 247:836-838; 1990.
99. 99. Nakao, A., Roijer, E., Imamura, T., Souchelnytskyi, S., Stenman, G., Heldin, C.-H., and ten Dijke, P. Identification of Smad, a human Mad-related protein in the transforming growth factor beta signaling pathway. J Biol Chem 272:2896-2900; 1997.
100. 100. Nakase, T., Nomura, S., Yoshikawa, H., Hashimoto, J., Hirota, S., Kitamura, Y., Oikawa, S., Ono, K., and Takaoka, K. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 9:651-659; 1994.
101. 101. Newfeld, S. J., Chartoff, E. H., Graff, J. M., Melton, D. A., and Gilbert, W. M. Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-β responsive cells. Development 122:2099-2108; 1996.
102. 102. Nishida, E. and Gotoh, Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18:128-131; 1993.
103. 103. Nishitoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., Enomoto, S., and Miyazono, K. Identification of type I and II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271:21345-21352; 1996.
104. 104. Nohno, T., Ishikawa, T., Hosokawa, K., Noji, S., Wolsing, D. H., and Rosenbaum, J. S. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 270:22522-22526; 1995.
105. 105. Okano, T., Ishidou, Y., Kato, M., Imamura, T., Yonemori, K., Origuchi, N., Matsunaga, S., Yoshida, H., ten Dijke, P., and Sakou, T. Orthotopic ossification of the spinal ligaments in Zucker fatty rats: A possible animal model for human ossification of the posterior longitudinal ligament. J Orthop Res. In press.
106. 106. Onishi, T., Ishidou, Y., Nagamine, T., Yone, K., Imamura, T., Kato, M., Sampath, T. K., ten Dijke, P., and Sakou, T. Distinct and overlapping patterns of localization of BMP family members and a BMP type II receptor during fracture healing in rats. Bone. In press.
107. 107. Özkaynak, E., Rueger, D. C., Drier, E. A., Corbett, C., Ridge, R. J., Sampath, T. K., and Oppermann, H. OP-1 cDNA encodes an osteogenic protein in the TGF-β family. Eur Mol Biol Org J 9:2085-2093; 1990.
108. 108. Özkaynak, E., Schnegelsberg, P. N. J., Jin, D. F., Clifford, G. M., Warren, F. D., Drier, E. A., and Oppermann, H. Osteogenic protein-2: A new member of the TGF-β superfamily expressed early in embryogenesis. J Biol Chem 267:25220-25227; 1992.
109. 109. Padgett, R. W., St. Johnston, D., and Gelbalt, W. M. A transcript from a Drosophila pattern gene predict a protein homologous to the transforming growth factor-β family. Nature 325:81-84; 1993.
110. 110. Padgett, R. W., Wozney, J. M., and Gelbert, W. M. Human BMP sequences can confer normal dorsal-ventral patterning in the Drosophila embryo. Proc Natl Acad Sci USA 90:2905-2909; 1993.
111. 111. Pfeilschifter, J., Wolf, O., Naumann, A., Minne, H., Mundy, G. R., and Ziegler, R. Chemotactic response of osteoblastlike cells to TGF-β. J Bone Miner Res 5:825-830; 1990.
112. 112. Rao, V. V. N. G., Löffler, C., Wozney, J. M., and Hansmann, I. The gene for BMP2A is localized to human chromosome 20p12 by radioactive and non-radioactive in situ hybridization. Human Genet 90:299; 1992.
113. 113. Reddi, A. H. Regulation of cartilage and bone differentiation by bone morphogenetic protein. Curr Opin Cell Biol 4:850-855; 1992.
114. 114. Reddi, A. H. Bone and cartilage differentiation. Curr Opin Genet Develop 4:737-744; 1994.
115. 115. Reddi, A. H. Bone morphogenetic proteins: An unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 8:11-20; 1997.
116. 116. Resnick, D., Guerra, J., Robinson, C. A., and Vint, V. C. Association of diffuse idiopathic skeletal hyperostosis (DISH) and calcification and ossification of the posterior longitudinal ligament. Am J Roentgenol 131:1049-1053; 1978.
117. 117. Riggins, G. J., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. K., Markowitz, S. D., Kinzler, K. W., and Vgelstein, B. Mad-related genes in the human. Nat Genet 13:347-349; 1996.
118. 118. Riley, E. H., Lane, J. M., Urist, M. R., Lyons, K. M., and Lieberman, J. R. Bone morphogenetic protein-2. Biology and application. Clin Orthop 324: 39-46; 1996.
119. 119. Ripamont, U., Heever, B. D., Sampath, T. K., Tucker, M. M., Ruegwer, D. C., and Reddi, A. H. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 123:273-289; 1996.
120. 120. Rosen, V., Thies, R. S., and Lyons, K. Signaling pathways in skeletal formation: A role for BMP receptors. Ann NY Acad Sci 785:59-69; 1996.
121. 121. Rosenzweig, B. L., Imamura, T., Okadome, T., Cox, G. N., Yamashita, H., ten Dijke, P., Heldin, C.-H., and Miyazono, K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632-7636; 1995.
122. 122. Sakou, T., Tomimura, K., Maehara, T., Morimoto, N., Yano, Y., Osako, T., Kawamura, H., Koji, T., Shibuya, E., Morizono, Y., and Ito, T. Pathogenesis of the ossification of the ligamentum flavum. Rinshyo Seikei Geka [Clin Orthop Surg] 12:368-376; 1977.
123. 123. Sakou, T., Taketomi, E., Matsunaga, S., Yamaguchi, M., Sonoda, S., and Yashiki, S. Genetic study of ossification of the posterior longitudinal ligament in the cervical spine with human leukocyte antigen haplotype. Spine 6:1249-1252; 1991.
124. 124. Sampath, T. K., Muthukumaran, N., and Reddi, A. H. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci USA 84:7109-7113; 1987.
125. 125. Sampath, T. K., Coughlin, J. E., Whetstone, R. M., Banach, D., Corbett, C., Ridge, R. J., Özkaynak, E., Oppermann, H., and Rueger, D. C. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-β superfamily. J Biol Chem 265: 13198-13250; 1990.
126. 126. Sampath, T. K., Maniacal, J. C., Hauschka, P. V., Jones, W. K., Sasak, H., Tucker, R. F., White, K. H., Coughlin, J. E., Tucker, M. M., Pang, R. H. L., Corbett, C., Özkaynak, E., Oppermann, H., and Rueger, D. C. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267:20352-20362; 1992.
127. 127. Sampath, T. K., Rashka, K. E., Doctor, J. S., Tucker, R. F., and Hoffmann, F. M. Drosophila TGF-β superfamily proteins induce endochondral bone formation in mammals. Proc Natl Acad Sci USA 90:6004-6008; 1993.
128. 128. Sampath, T. K. and Rueger, D. C. Structure, function, and orthopedic application of osteogenic protein-1 (OP-1). Compli Orthop Winter: 101-107; 1994.
129. 129. Savage, C., Das, P., Finelli, A., Townsend, S., Sun, C., Bairrd, S., and Padgett, R. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a novel conserved family of transforming growth factor β pathway components. Proc Natl Acad Sci USA 93:790-794; 1996.
130. 130. Shafritz, A. B., Shore, E. M., Gannon, F. H., Zasloff, M. A., Taub, R., Muenke, M., and Kaplan, F. S. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335:555-561; 1996.
131. 131. Shah, N. M., Groves, A. K., and Anderson, D. J. Alternative neural crest cell fates are instructively promoted by TGFβ superfamily members. Cell 85:331-343; 1996.
132. 132. Sekelsky, J. J., Newfeld, S. J., Raftery, L. A., Chartoff, E. H., and Gelbart, W. M. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentalegic function in Drosophila melanogaster. Genetics 139:1347-1358; 1995.
133. 133. Smith, W. C. and Harland, R. M. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70:829-840; 1992.
134. 134. Song, J. J., Celeste, A. J., Kong, F.-M., Jirtle, R. L., Rosen, V., and Thies, R. S. Bone morphogenetic protein-9 binds to liver cells stimulates proliferation. Endocrinology 136:4293-4297; 1995.
135. 135. Storm, E. E., Huynh, T. V., Copeland, N. G., Jenkins, N. A., Kingsley, D. M., and Lee, S.-J. Limb alterations in brachypodism mice due to mutations in a new member of the TGF-β superfamily. Nature 368:639-643; 1994.
136. 136. Storm, E. E. and Kingsley, D. M. Joint pattering defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 122:3969-3979; 1996.
137. 137. Suzuki, A., Kaneko, E., Maeda, J., and Ueno, N. Mesoderm induction by BMP-4 and -7 heterodimer. Biochem Biophys Res Commun 232:153-156; 1997.
138. 138. Tabas, J. A., Hahn, A. G. V., Cohen, R. B., Seaunez, H. N., Modi, W. S., Wozney, J. M., Zasloff, M., and Kaplan, F. S. Chromosomal assignment of the human gene for bone morphogenetic protein 4. Clin Orthop 293:310-316; 1993.
139. 139. Taketomi, E., Sakou, T., and Matsunaga, S. Conservative treatment of ossification of the posterior longitudinal ligament. In: Yonenobu, K., Sakou, T., and Ono, K., Eds. OPLL. Tokyo: Springer; 1997; 131-142.
140. 140. Takuwa, Y., Ohse, C., Wang, E. A., Wozney, J. M., and Yamashita, K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun 174:96-101; 1991.
141. 141. ten Dijke, P., Yamashita, H., Sampath, T. K., Reddi, A. H., Estevez, M., Riddle, D. L., Ichijo, H., Heldin, C.-H., and Miyazono, K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269:16985-16988; 1994.
142. 142. ten Dijke, P., Miyazono, K., and Heldin, C.-H. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Opin Cell Biol 8:139-145; 1996.
143. 143. Thies, R. S., Bauduy, M., Ashton, B. A., Kurtzberg, L., Wozney, J. M., and Rosen, V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-1324; 1992.
144. 144. Thomas, J. T., Lin, K., Nandedkar, M., Camargo, M., Cervenka, J., and Luyten, F. P. A human chondrodysplasia due to a mutation in a TGF-β superfamily member. Nature Genet 12:315-317; 1996.
145. 145. Thomsen, G. H. Xenopus mothers against decapentalgic is an embryonic ventralizing agent that acts downstream of BMP-2/-4 receptor. Development 122:2359-2366; 1996.
146. 146. Toriumi, D. M., Kotler, H. S., Luxenberg, D. P., Holtrop, M. E., and Wang, E. A. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 117:1101-1112; 1991.
147. 147. Tsukamoto, T., Matsui, T., Fukase, M., and Fujita, T. Platelet-derived growth factor B chain homodimer enhances chemotaxis and DNA synthesis in normal osteoblast-like cells (MC3T3-E1). Biochem Biophys Res Commun 175:745-751; 1991.
148. 148. Urist, M. R. Bone formation by autoinduction. Science 150:893-899; 1965.
149. 149. Urist, M. R. Practical application of basic research on bone graft physiology. AAOS Instr Course Lee 25:1-26; 1976.
150. 150. Urist, M. R. and Dawson, E. Intertransverse process fusion with the aid of chemosterized autolyzed antigen-extracted allogenic (AAA) bone. Clin Orthop 154:97-113; 1981.
151. 151. Urist, M. R., Sato, K., Brownell, A. G., Malinin, T. I., Lietze, A., Huo, Y. K., Prolo, D. J., Okuund, S., Finerman, G. A., and Delange, R. J. Human bone morphogenetic protein (hBMP). Proc Soc Exp Biol Med 173:194-199; 1983.
152. 152. Vukicevic, S., Luyten, F. P., and Reddi, A. H. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci USA 86:8793-8797; 1989.
153. 153. Vukicevic, S., Latin, V., Chen, P., Batorsky, R., Reddi, A. H., and Sampath, T. K. Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: High affinity binding to basement membranes. Biochem Biophys Res Commun 198:693-700; 1994.
154. 154. Wall, N. A., Blessing, M., Wright, C. V. E., and Hogan, B. L. M. Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein, DVR-6 (bone morphogenetic protein-6). J Cell Biol 120:493-502; 1993.
155. 155. Wang, E. A., Rosen, V., Cordes, P., Hewich, R. M., Kriz, M. J., Luxenberg, D. P., Sibley, B. S., and Wozney, J. M. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 85:9484-9488; 1988.
156. 156. Wang, E. A., Rosen, V. D., D'Alessandro, J. S., Bauduy, M., Cordes, P., Harada, T., Israel, D., Hewick, R. M., Kern, K. M., LaPan, P., Luxenberg, D. P., McQuaid, D., Moutsatsos, I. K., Nove, J., and Wozney, J. M. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220-2224; 1990.
157. 157. Wang, E. A., Israel, D., Kelly, S., and Luxenburg, D. P. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 19:57-71; 1993.
158. 158. Wieser, R., Attisano, L., Wrana, J. L., and Massagué, J. Signaling activity of TGF-β type II receptors lacking specific domains in the cytoplasmic regions. Mol Cell Biol 13:7239-7247; 1993.
159. 159. Wieser, R., Wrana, J. L., and Massagué, J. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. Eur Mol Biol Org J 14:2199-2208; 1995.
160. 160. Winner, G., Blessing, M., Labosky, P. A., and Hogan, B. L. M. Bone morphogenetic protein-4 is required for mesodermal formation and patterning in the mouse. Genes Dev 9:2105-2116; 1995.
161. 161. Wolfman, N. M., Hattersley, G., Cox, K., Celeste, A. J., Nelson, R., Yamaji, N., Dube, J. L., DiBlasio-Smith, E., Nove, J., Song, J. J., Wozney, J. M., and Rosen, V. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-β gene family. J Clin Invest 100:321-330; 1997.
162. 162. Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kritz, R. W., Hewick, R. M., and Wang, E. A. Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534; 1988.
163. 163. Wozney, J. M. Bone morphogenetic proteins and their gene expression. In: Noda, M., Eds. Cellular and Molecular Biology of Bone. San Diego: Academic; 1993; 131-167.
164. 164. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. Mechanism of activation of the TGF-β receptor. Nature 370:341-347; 1994.
165. 165. Yamaguchi, A., Katagiri, T., Ikeda, T., Wozney, J. M., Rosen, V., Wang, E. A., Kahn, A. J., Suda, T., and Yoshiki, S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-687; 1991.
166. 166. Yamaguchi, A. Relation of differentiation pathway of skeletal mesenchymal cell in cell lines by transforming growth factor-β superfamily. J Cell Biol 6:165-173; 1995.
167. 167. Yamashita, H., ten Dijke, P., Franzén, P., Miyazono, K., and Heldin, C. H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem 269:20172-20178; 1994.
168. 168. Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T. K., Andries, M., Smith, J. C., Heldin, C.-H., and Miyazono, K. Osteogenic protein-1 binds to activin type II receptors and induce certain activin like effects. J Cell Biol 130:217-226; 1995.
169. 169. Yamashita, H., ten Dijke, P., Heldin, C.-H., and Miyazono, K. Bone morphogenetic protein receptors. Bone 19:569-574; 1996.
170. 170. Yamashita, H., Shims, A., Kato, M., Nishitoh, H., Ichijo, H., Hanyu, A., Morita, I., Kimura, M., Makishima, F., and Miyazono, K. Growth/differentiation factor-5 induces angiogenesis in vivo. Exp Cell Res 235:218-226; 1997.
171. 171. Yasko, A. W., Lane, J. M., Fellinger, E. F., Rosen, V., Wozney, J. M., and Wang, E. A. The healing of segmental defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Jt Surg 74-A:659-670; 1992.
172. 172. Yokouchi, Y., Sakiyama, J., Kameda, T., Iba, H., Suzuki, A., Ueno, N., and Kuroiwa, A. BMP-2/-4 mediate programmed cell death in chicken limb buds. Development 122:3725-3734; 1996.
173. 173. Yonemori, K., Imamura, T., Ishidou, Y., Okano, T., Matsunaga, S., Yoshida, H., Kato, M., Sampath, T. K., Miyazono, K., ten Dijke, P., and Sakou, T. Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissue of patients with ossification of the posterior longitudinal ligament. Am J Pathol 150:1335-1347; 1997.
174. 174. Zhang, H. and Bradley, A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122:2977-2986; 1996.
175. 175. Zhao, G. O., Deng, K., Labosky, P. A., Liaw, L., and Hogan, B. L. M. The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev 10:1657-1669; 1996.
176. 176. Zimmerman, L. B., De Jesus-Escobar, J. M., and Harland, R. M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86:599-606; 1996.
177. 177. Zou, H. and Niswander, L. Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272:738-741; 1996.
178. 178. Zou, H., Wieser, R., Massague, J., and Niswander, L. Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes Dev 11:2191-2203; 1997.
179. 179. Zucker, L. M. and Zucker, T. Fatty, a new mutation in the rat. J Hered 52:275-278; 1961.
180. 180. Zusman, S. B., Sweeton, D., and Wieschaus, E. F. Short gastrulation, a mutation causing delays in stage-specific cell shape changes during gastrulation in Drosophila melanogaster. Dev Biol 129:417-427; 1988.